Physician

Benjamin Reiss, M.D.

According to 2025 Medicare claims, Benjamin Reiss, M.D. (NPI: 1659637668) practices ophthalmology in the Seattle-Bellevue-Kent, WA market, with the plurality of this provider's patient population coming from King, WA. This provider's primary affiliated billing organization is WASHINGTON RETINA, PLLC (NPI: 1215672084; TIN: 881667866) and primary practice location at 98002-4035. Reiss is affiliated with the MultiCare Connected Care, LLC (ACO ID: A3631), participating under the MSSP model.

Reiss' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 603 traditional Medicare patients, billed 42,050 HCPCS/CPT codes, and received $2,230,170 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 367 prescription claims across 154 beneficiaries totaling $13,344 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 11 records totaling $399. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $4,547 to $2,230,170. Similarly, Part D prescription costs have risen steadily, from $1,367 to $13,344. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2016 Medicare payment: $4,547 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $25,177 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $125,228 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $587,252 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $814,440 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,185,678 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $923,274 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,934,162 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,230,170 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20162940$4,547
2017159277$25,177
20182331,176$125,228
20194024,691$587,252
20204804,893$814,440
20216746,695$1,185,678
20226355,216$923,274
202363722,875$1,934,162
202460342,050$2,230,170

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$9.4K$19K2015 Drug cost: $1,367 (USD; Tot_Drug_Cst)2016 Drug cost: $2,941 (USD; Tot_Drug_Cst)2017 Drug cost: $1,426 (USD; Tot_Drug_Cst)2018 Drug cost: $3,925 (USD; Tot_Drug_Cst)2019 Drug cost: $14,840 (USD; Tot_Drug_Cst)2020 Drug cost: $14,364 (USD; Tot_Drug_Cst)2021 Drug cost: $14,932 (USD; Tot_Drug_Cst)2022 Drug cost: $10,532 (USD; Tot_Drug_Cst)2023 Drug cost: $18,782 (USD; Tot_Drug_Cst)2024 Drug cost: $13,344 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151121$1,367
20161934$2,941
20171542$1,426
20183693$3,925
2019103313$14,840
2020108330$14,364
2021118327$14,932
202274200$10,532
2023161433$18,782
2024154367$13,344

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2391,009$105
92014Established patient complete exam of visual system447713$98
92012Established patient problem focused exam of visual system198467$75
92134Imaging of retina4621,337$33
92250Photography of the retina336386$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1375,197$7,218
Ketorolac TromethamineKetorolac Tromethamine391,504$947
OfloxacinOfloxacin791,656$874
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat302,231$449
Dorzolamide HclDorzolamide Hcl11786$322

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$399Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Benjamin Reiss, M.D.?

Tedicare shows public-source Medicare data for Benjamin Reiss, M.D. (NPI 1659637668), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin Reiss, M.D. have ACO affiliation data?

Benjamin Reiss, M.D. is shown with ACO affiliation data for MultiCare Connected Care, LLC (MSSP, ACO ID A3631).

What billing organization is linked to Benjamin Reiss, M.D.?

Benjamin Reiss, M.D. is linked to WASHINGTON RETINA, PLLC (billing NPI 1215672084) in the available physician profile data.

Does Benjamin Reiss, M.D. have Open Payments data?

Benjamin Reiss, M.D. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.